Molecular Therapy - Table of Contents alert Volume 20 Issue 11

TABLE OF CONTENTS Volume 20, Issue 11 (November 2012) In this issue Editorial In This Issue Research Highlights Commentaries Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe The publication of this issue was delayed due to Hurricane Sandy closing our New York offices temporarily. We apologize for any inconvenience caused. Advertisement Be part of the research that is changing the course of medicine! Molecular Therapy is the leading international journal for basic, translational and clinical research aimed at the development of novel cell and gene therapy approaches to treat disease. To submit your research or view the complete Guide to Authors visit www.nature.com/mt/author_instructions.html   Editorial Top Introducing a New ASGCT Forum for Publication of Methodology and Clinical Development in Gene, Cell, and Oligonucleotide Therapies Robert M Frederickson and Malcolm K Brenner Mol Ther 2012 20: 2005-2006; 10.1038/mt.2012.215 Full Text In This Issue Top In This Issue Mol Ther 2012 20: 2008; 10.1038/mt.2012.216 Full Text Research Highlights Top Research Highlights Mol Ther 2012 20: 2009; 10.1038/mt.2012.217 Full Text Commentaries Top RNAi Joins the “Singles Club” Veronica J. Peschansky, Zicai Liang and Claes Wahlestedt Mol Ther 2012 20: 2010-2011; 10.1038/mt.2012.218 Full Text Converting Pathological Cells to Therapeutic Ones: An Odyssey Through Pluripotency Jean-Thomas Vilquin Mol Ther 2012 20: 2012-2014; 10.1038/mt.2012.219 Full Text rAAV-Mediated Tumorigenesis: Still Unresolved After an AAV Assault Paul N Valdmanis, Leszek Lisowski and Mark A Kay Mol Ther 2012 20: 2014-2017; 10.1038/mt.2012.220 Full Text A New Vision of Mesenchymal Stromal Cells Richard L Hurwitz Mol Ther 2012 20: 2017-2018; 10.1038/mt.2012.221 Full Text Original Articles Top Restoration of Vision in the pde6β-deficient Dog, a Large Animal Model of Rod-cone Dystrophy Lolita Petit, Elsa Lhériteau, Michel Weber, Guylène Le Meur, Jack-Yves Deschamps, Nathalie Provost, Alexandra Mendes-Madeira, Lyse Libeau, Caroline Guihal, Marie-Anne Colle, Philippe Moullier and Fabienne Rolling Mol Ther 2012 20: 2019-2030; advance online publication, July 24, 2012; 10.1038/mt.2012.134 Abstract | Full Text Extended Normal Life After AAVrh10-mediated Gene Therapy in the Mouse Model of Krabbe Disease Mohammad A Rafi, Han Zhi Rao, Paola Luzi, Mark T Curtis and David A Wenger Mol Ther 2012 20: 2031-2042; advance online publication, July 31, 2012; 10.1038/mt.2012.153 Abstract | Full Text Oral Administration of Recombinant Adeno-associated Virus-mediated Bone Morphogenetic Protein-7 Suppresses CCl4-induced Hepatic Fibrosis in Mice Zhi-Ming Hao, Min Cai, Yi-Fei Lv, Yan-Hua Huang and Hong-Hong Li Mol Ther 2012 20: 2043-2051; advance online publication, July 31, 2012; 10.1038/mt.2012.148 Abstract | Full Text GOLGA2/GM130, cis-Golgi Matrix Protein, is a Novel Target of Anticancer Gene Therapy Seung-Hee Chang, Seong-Ho Hong, Hu-Lin Jiang, Arash Minai-Tehrani, Kyeong-Nam Yu, Jae-Ho Lee, Ji-Eun Kim, Ji-Young Shin, Bitna Kang, Sungjin Park, Kiwon Han, Chanhee Chae and Myung-Haing Cho Mol Ther 2012 20: 2052-2063; advance online publication, June 26, 2012; 10.1038/mt.2012.125 Abstract | Full Text Phage Display-directed Discovery of LEDGF/p75 Binding Cyclic Peptide Inhibitors of HIV Replication Belete A Desimmie, Michael Humbert, Eveline Lescrinier, Jelle Hendrix, Sofie Vets, Rik Gijsbers, Ruth M Ruprecht, Ursula Dietrich, Zeger Debyser and Frauke Christ Mol Ther 2012 20: 2064-2075; advance online publication, July 24, 2012; 10.1038/mt.2012.132 Abstract | Full Text An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance Vincenzo Cerullo, Iulia Diaconu, Valentina Romano, Mari Hirvinen, Matteo Ugolini, Sophie Escutenaire, Sirkka-Liisa Holm, Anja Kipar, Anna Kanerva and Akseli Hemminki Mol Ther 2012 20: 2076-2086; advance online publication, July 24, 2012; 10.1038/mt.2012.137 Abstract | Full Text Terminal Differentiation of Cardiac and Skeletal Myocytes Induces Permissivity to AAV Transduction by Relieving Inhibition Imposed by DNA Damage Response Proteins Jasmina Lovric, Miguel Mano, Lorena Zentilin, Ana Eulalio, Serena Zacchigna and Mauro Giacca Mol Ther 2012 20: 2087-2097; advance online publication, July 31, 2012; 10.1038/mt.2012.144 Abstract | Full Text Patterns of scAAV Vector Insertion Associated With Oncogenic Events in a Mouse Model for Genotoxicity Lucia E Rosas, Jessica L Grieves, Kimberly Zaraspe, Krista MD La Perle, Haiyan Fu and Douglas M McCarty Mol Ther 2012 20: 2098-2110; advance online publication, September 18, 2012; 10.1038/mt.2012.197 Abstract | Full Text The Extragenic Spacer Length Between the 5′ and 3′ Ends of the Transgene Expression Cassette Affects Transgene Silencing From Plasmid-based Vectors Jiamiao Lu, Feijie Zhang, Siqun Xu, Andrew Z Fire and Mark A Kay Mol Ther 2012 20: 2111-2119; advance online publication, May 8, 2012; 10.1038/mt.2012.65 Abstract | Full Text Muscle Function Recovery in Golden Retriever Muscular Dystrophy After AAV1-U7 Exon Skipping Adeline Vulin, Inès Barthélémy, Aurélie Goyenvalle, Jean-Laurent Thibaud, Cyriaque Beley, Graziella Griffith, Rachid Benchaouir, Maëva le Hir, Yves Unterfinger, Stéphanie Lorain, Patrick Dreyfus, Thomas Voit, Pierre Carlier, Stéphane Blot and Luis Garcia Mol Ther 2012 20: 2120-2133; advance online publication, September 11, 2012; 10.1038/mt.2012.181 Abstract | Full Text Exon 45 Skipping Through U1-snRNA Antisense Molecules Recovers the Dys-nNOS Pathway and Muscle Differentiation in Human DMD Myoblasts Valentina Cazzella, Julie Martone, Chiara Pinnarò, Tiziana Santini, Shyam Sundar Twayana, Olga Sthandier, Adele D'Amico, Valeria Ricotti, Enrico Bertini, Francesco Muntoni and Irene Bozzoni Mol Ther 2012 20: 2134-2142; advance online publication, September 11, 2012; 10.1038/mt.2012.178 Abstract | Full Text Intravenous Mesenchymal Stem Cells Prevented Rejection of Allogeneic Corneal Transplants by Aborting the Early Inflammatory Response Joo Youn Oh, Ryang Hwa Lee, Ji Min Yu, Jung Hwa Ko, Hyun Ju Lee, Ah Young Ko, Gavin W Roddy and Darwin J Prockop Mol Ther 2012 20: 2143-2152; advance online publication, August 28, 2012; 10.1038/mt.2012.165 Abstract | Full Text Myoblasts Derived From Normal hESCs and Dystrophic hiPSCs Efficiently Fuse With Existing Muscle Fibers Following Transplantation Sébastien Goudenege, Carl Lebel, Nicolas B Huot, Christine Dufour, Isao Fujii, Jean Gekas, Joël Rousseau and Jacques P Tremblay Mol Ther 2012 20: 2153-2167; advance online publication, September 18, 2012; 10.1038/mt.2012.188 Abstract | Full Text Proinflammatory Macrophages Enhance the Regenerative Capacity of Human Myoblasts by Modifying Their Kinetics of Proliferation and Differentiation Maximilien Bencze, Elisa Negroni, Denis Vallese, Houda Yacoub–Youssef, Soraya Chaouch, Annie Wolff, Ahmed Aamiri, James P Di Santo, Bénédicte Chazaud, Gillian Butler-Browne, Wilson Savino, Vincent Mouly and Ingo Riederer Mol Ther 2012 20: 2168-2179; advance online publication, October 16, 2012; 10.1038/mt.2012.189 Abstract | Full Text Chemoselection of Allogeneic HSC After Murine Neonatal Transplantation Without Myeloablation or Post-transplant Immunosuppression Rustom Falahati, Jianqing Zhang, Linda Flebbe-Rehwaldt, Yimin Shi, Stanton L Gerson and Karin ML Gaensler Mol Ther 2012 20: 2180-2189; advance online publication, August 7, 2012; 10.1038/mt.2012.136 Abstract | Full Text Molecular Therapy-Nucleic Acids Online.Open Access.High-Quality Research. Molecular Therapy-Nucleic Acids is a peer-reviewed, fully open access, online journal. Sibling journal to the well-established high impact journal, Molecular Therapy. The journal publishes high quality basic, translational, and clinical research and cutting edge reviews and commentaries targeted to the advances in oligonucleotide- and gene-based therapies. Submit your research TODAY!!   Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.